Further, our results illustrated that SDS-203 treatment failed to overexpress LC3-II and LAMP-1 expression in transiently mTORC1 upregulated pancreatic cancer cells compared to control (Fig. 6D–G). Here, LAMP1 is linked to familial pancreatic carcinoma.